HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Placenta Diseases (Placenta Disorder)

Subscribe to New Research on Placenta Diseases

Pathological processes or abnormal functions of the PLACENTA.

Also Known As:

Placenta Disorder; Placenta Disorders; Placental Diseases; Disease, Placenta; Disease, Placental; Diseases, Placenta; Diseases, Placental; Disorder, Placenta; Disorders, Placenta; Placenta Disease; Placental Disease

Networked: 29 relevant articles (1 outcomes, 4 trials/studies)

Relationship Network

Disease Context: Research Results

Female Urogenital Diseases and Pregnancy Complications
- Pregnancy Complications: 986
  - Placenta Diseases: 29

Related Diseases

1.	Neoplasm Metastasis (Metastasis)
2.	Pre-Eclampsia (Preeclampsia)
3.	Pregnancy Complications
4.	Fetal Growth Retardation (Intrauterine Growth Retardation)
5.	Hyperhomocysteinemia

Experts

1.	Chelbi, Sonia T: 2 articles (01/2014 - 03/2010)
2.	Vaiman, Daniel: 2 articles (01/2014 - 03/2010)
3.	Giannubilo, Stefano R: 2 articles (06/2011 - 03/2004)
4.	Tranquilli, Andrea L: 2 articles (06/2011 - 03/2004)
5.	Pirinen, Elina: 1 article (06/2014)
6.	Soini, Ylermi: 1 article (06/2014)
7.	Aboussaouira, Touria: 1 article (01/2014)
8.	Benharouga, Mohamed: 1 article (01/2014)
9.	Winter, Michael R: 1 article (01/2014)
10.	Houry, Dorothée: 1 article (01/2014)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Placenta Diseases:

1.	Folic Acid (Vitamin M)FDA LinkGeneric 04/01/2004 - "Results of many studies suggest that hyperhomocysteinemia, homozygous state for MTHFR gene mutation, folate deficiency are probably risk factors for recurrent fetal loss, intrauterine fetal death, thrombo-embolic disease in pregnancy, neural tube defects and congenital cardiac malformation at infants and other placental diseases (pre-eclampsia, placental abruption and intrauterine growth restriction IUGR). " 09/01/1999 - "Deficiencies of vitamin B12 and folate, or other abnormalities within the methionine-homocyst(e)ine pathway have been implicated in the development of such placental diseases. "
2.	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 05/01/2004 - "This strategy of identifying thrombo-occlusive placental lesions before the development of pregnancy complications may prove useful in the design of trials to study the effectiveness of LMWH in the prevention of clinical complications resulting from thrombo-occlusive placental disease."
3.	claudin 4IBA 06/01/2014 - "The study implicates that twist and zeb1 are involved in placental maturation, whereas claudin 4 appears to be connected with placental diseases such as diabetes, toxaemia or molar disease. "
4.	HLA-G antigen (HLA G)IBA 06/01/2011 - "Therefore, studies on placental diseases should address HLA-G expression and genetic variations also to the fetus/placenta."
5.	MicroRNAs (MicroRNA)IBA 01/01/2014 - "Several placental microRNAs (miRNAs) have been shown to be deregulated in the context of placental diseases and could thus play a role in the pathophysiology of PE. " 09/01/2010 - "Together, our results show that plasma concentration of miRNAs is regulated in pregnancy, and that FGR is associated with increased circulating miRNA levels, highlighting the need to explore plasma miRNAs as potential biomarkers for placental diseases."
6.	Proteins (Proteins, Gene)IBA 03/10/2010 - "Overall, the use of iTRAQ technology, for the first time on this subject, enabled us to provide a new list of proteins modified in placental diseases, among which proteins expressed at a low level that were not accessible by other methods." 04/01/2009 - "Relatively little is known about the proteins that reside in this unique plasma membrane or how they may change in various placental diseases. " 03/10/2010 - "In order to identify new protein markers modified in placental diseases, high-throughput analysis of proteins in the plasma of pregnant women was carried out for normal and pathological pregnancies (Preeclampsia and/or Intra-Uterine Growth Restriction) using iTRAQ technology. "
7.	AdiponectinIBA 10/01/2010 - "Relationships among adiponectin gene polymorphisms, proteinuria and increased blood pressure in the context of placental diseases."
8.	Cullin Proteins (Cullins)IBA 02/01/2010 - "Our work hypothesis is that Cullins, particularly CUL4B and CUL7, are involved in placental diseases and especially in IUGR. "
9.	Endocrine-Gland-Derived Vascular Endothelial Growth Factor (Vascular Endothelial Growth Factor, Endocrine Gland Derived)IBA 01/01/2014 - "This review recapitulates EG-VEGF mediated-angiogenesis within the placenta and at the fetomaternal interface and proposes that its deregulation might contribute to the pathogenesis of several placental diseases including FGR and PE. "
10.	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/15/2004 - "Low concentrations of VEGF and NO in the second trimester may represent an impaired stimulus to vascular formation and endothelial regulation that induce placental disease and preeclampsia."

Therapies and Procedures

1.	Drug Therapy (Chemotherapy) 07/01/2006 - "Gestational trophoblastic diseases (GTD), a group of rare placenta disorders, have a varying potential for invasion, either local, or remote under the form of metastases, and are definitely cured by chemotherapy in 85 to 99% of cases. "
2.	Cesarean Section (Caesarean Section) 12/01/2009 - "Bleeding during pregnancy was also more common in cases than controls (p = 0.032), while the breech presentation, emergency cesarean section, hydrocephalus, placenta disorders and pre-eclampsia were not associated with CP. "
3.	General Anesthesia 07/01/2005 - "Risk factors for PPH after an elective operation included leiomyomata, blood disorders, placenta previa, antepartum bleeding, preterm birth, and general anesthesia. "